Rebecca Byam, Chief Financial Officer at HCW Biologics Inc. (HCWB), bought 17,200 shares at $2.56 ($44K) on 2022-08-31, disclosed to the SEC on 2022-09-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.55 | 7,200 | $18K | 41.8% |
| 2 | $2.56 | 10,000 | $26K | 58.2% |
| Total | $2.56 avg | 17,200 | $44K | 100% |
| Filing → |
| HCWB | BUY | 2023-09-15 | $11K | — | Filing → |
| HCWB | BUY | 2023-09-13 | $21K | — | Filing → |
| HCWB | BUY | 2023-09-08 | $20K | — | Filing → |